Healthcare provider profile · identity verified

Jose Padron, M.D.

Internal Medicine · MIAMI, FL · NPI 1578598603

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	826	284
Losartan Potassium	Losartan Potassium	495	174
Levothyroxine Sodium	Levothyroxine Sodium	435	128
Amlodipine Besylate	Amlodipine Besylate	402	134
Metoprolol Succinate	Metoprolol Succinate	330	102
Fluticasone Propionate	Fluticasone Propionate	324	129
Lisinopril	Lisinopril	313	107
Omeprazole	Omeprazole	309	104
Simvastatin	Simvastatin	305	96
Famotidine	Famotidine	268	109
Gabapentin	Gabapentin	251	91
Metformin Hcl	Metformin Hcl	232	79
Carvedilol	Carvedilol	223	63
Rosuvastatin Calcium	Rosuvastatin Calcium	222	83
Tamsulosin Hcl	Tamsulosin Hcl	220	80
Eliquis	Apixaban	189	52
Albuterol Sulfate Hfa	Albuterol Sulfate	175	31
Vitamin D2	Ergocalciferol (Vitamin D2)	173	56
Hydrochlorothiazide	Hydrochlorothiazide	160	60
Trazodone Hcl	Trazodone Hcl	154	57
Alendronate Sodium	Alendronate Sodium	149	49
Pantoprazole Sodium	Pantoprazole Sodium	137	50
Escitalopram Oxalate	Escitalopram Oxalate	134	46
Furosemide	Furosemide	129	37
Montelukast Sodium	Montelukast Sodium	117	45
Clopidogrel	Clopidogrel Bisulfate	109	37
Alcohol Prep Pads	Alcohol Antiseptic Pads	103	26
Irbesartan	Irbesartan	96	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	96	33
Metoprolol Tartrate	Metoprolol Tartrate	93	36
Sildenafil Citrate	Sildenafil Citrate	93	28
Farxiga	Dapagliflozin Propanediol	91	12
Linzess	Linaclotide	89	11
Finasteride	Finasteride	82	22
Donepezil Hcl	Donepezil Hcl	79	33
Ketoconazole	Ketoconazole	74	35
Spironolactone	Spironolactone	70	21
Atenolol	Atenolol	64	24
Dicyclomine Hcl	Dicyclomine Hcl	61	26
Azithromycin	Azithromycin	57	53
Buspirone Hcl	Buspirone Hcl	56	21
Xarelto	Rivaroxaban	56	12
Memantine Hcl	Memantine Hcl	52	23
Sertraline Hcl	Sertraline Hcl	51	18
Janumet	Sitagliptin Phos/Metformin Hcl	49	11
Januvia	Sitagliptin Phosphate	49	15
Allopurinol	Allopurinol	48	16
Chlorthalidone	Chlorthalidone	47	13
Symbicort	Budesonide/Formoterol Fumarate	47	suppressed
Brilinta	Ticagrelor	46	suppressed
Enalapril Maleate	Enalapril Maleate	46	16
Nifedipine Er	Nifedipine	43	14
Pravastatin Sodium	Pravastatin Sodium	42	14
Benazepril Hcl	Benazepril Hcl	41	suppressed
Ozempic	Semaglutide	41	11
Alprazolam	Alprazolam	39	14
Ciclopirox	Ciclopirox	39	25
Digoxin	Digoxin	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	15
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	19
Hydrocortisone	Hydrocortisone	37	15
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Spiriva Respimat	Tiotropium Bromide	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	20
Entresto	Sacubitril/Valsartan	35	suppressed
Latanoprost	Latanoprost	35	15
Lumigan	Bimatoprost	35	suppressed
Glipizide	Glipizide	32	13
Ezetimibe	Ezetimibe	31	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	21
Glimepiride	Glimepiride	30	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Bumetanide	Bumetanide	28	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Veltassa	Patiromer Calcium Sorbitex	28	24
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Mirtazapine	Mirtazapine	27	12
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Ammonium Lactate	Ammonium Lactate	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Ciclopirox	Ciclopirox Olamine	23	suppressed
Ramipril	Ramipril	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Bydureon Bcise	Exenatide Microspheres	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Lactulose	Lactulose	21	13
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Vascepa	Icosapent Ethyl	21	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Fosinopril Sodium	Fosinopril Sodium	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Timolol Maleate	Timolol Maleate	19	suppressed
Valsartan	Valsartan	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Cephalexin	Cephalexin	18	16
Clonazepam	Clonazepam	18	suppressed
Dutasteride	Dutasteride	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Restasis	Cyclosporine	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Mupirocin	Mupirocin	17	13
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Levofloxacin	Levofloxacin	16	15
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	16
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Novolog	Insulin Aspart	15	suppressed
Ssd	Silver Sulfadiazine	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Gemtesa	Vibegron	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Combigan	Brimonidine Tartrate/Timolol	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Livalo	Pitavastatin Calcium	11	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error